COMPARE · Reviewed August 3, 2026
CON vs FMS
Verdict: Side-by-side breakdown using the Bull Rankings model. CON scored 71.3, FMS scored 72.1 — FMS leads.
Compare another set
Different reporting periods. CON's fundamentals are as of March 2026, but FMS's are as of December 2016 — a 113-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
CON
Concentra Group Holdings Parent, Inc.
71.3
$31.70 · $4.1B
fundamentals as of
Score gap
0.8
FMS leads
FMS
Fresenius Medical Care AG
72.1
$25.26 · $13.6B
fundamentals as of
The model, pillar by pillar (0–100 each)
CON
stronger →← stronger
FMS
73
Qualityreturns · margins · balance sheet
75
86
Growthrevenue & earnings expansion
75
58
Valuevaluation vs sector peers
78
FMS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
CON
FMS
$211mC
FCF
$1.1bC+
+15.5%B+
Rev
+5.9%C+
4.68D
D/E
0.78C+
22.8xB+
P/E
13.4xA-
1.65C+
PEG
0.91B+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
CON
FMS
25% below
Price vs fair valuelower is cheaper
40% below
~1%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-5%/yr
+19%
1-yr DCF upside
+50%
+33%
5-yr DCF upside
+68%
+58%
10-yr DCF upside
+99%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CON
Why this score
- Durable high returns
- Short track record
FMS
Why this score
- Buying back stock
- Foreign reporter (EUR)
The companies
CONConcentra Group Holdings Parent, Inc.
Why now
Medical Care Facilities · market cap $4.1b. 4% off the 52-week high of $32.86. Revenue growing +15%, comfortably above the S&P median. 8 sell-side analysts publish a mean 1-yr target of $33.38 (implying +5% upside).
Moat
ROE 42% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 119% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
D/E 4.68 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer.
FMSFresenius Medical Care AG
Why now
Medical Care Facilities · market cap $13.6b. 9% off the 52-week high of $27.64. PEG 0.91 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Hold with a mean 1-yr target of $25.95 (implying +3% upside).
Moat
Net margin 24% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.